Editorial on Journal of Nanoscience and Nanomedicine

This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact reprints@pulsus.com

Abstract

Editorial Note

On behalf of the Board of the Journal of Nanoscience and Nanomedicine, it is a pulsus publisher with 25 million website visitors, mainly functions as a global platform for the exchange of knowledge within and across the medical science community. Use of nanotechnology in the field of nanomedicine medicine and Nanotherapeutics help in reduction in drug volume, avoiding the problem of accumulation in healthy tissue. Nanomedicine also applies to drugs that are quickly absorbed and removed from the body before treatment. Nanomedicine increases the duration of an active period in the body. The Journal envisages basic and applied aspects of natural and synthetic nanoparticle generation and analysis, molecular nanotechnology studies, biomedical applications of nano sensors, nanoelectronics, nanorobotics, etc.

According to the year 2019 the main objective of Journal of Nanoscience and Nanomedicine is to publish up-to-date, high-quality and original research papers. The journal mainly highlights on all the issues of volume 3 were published online well within the time and Within 30 days of the publication of the online issue, printing problems were also addressed. The research article entitled “Niosome encapsulated fluorouracil as drug delivery system to basal-cell skin cancer’’ brought a great scope to this journal by the authors named Dr. Saiavash Hosseinpour Chermahini and Dr. Rahim Bahri Najafi from Department of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Science, Isfahan University of Medical Sciences, Isfahan, Iran. Journal of Nanoscience and Nanomedicine also provide an editorial from the editors such as conference announcement, market analysis, awards 2020, past conference report etc, and handling with a special issue on Nanotechnology Letters.

The journal particularly stressed on the publications of manuscripts by showcasing the real time applicability of nanotechnology based biomedical interventions, including for the toxic responses against administration of nanomedicines that serve to accentuate research and development of novel nanodrugs and nano biopharmaceutical agents. The journal accepts manuscripts in the form of research articles, review articles, case reports, short communications, clinical images, opinion articles, etc. All submitted manuscripts are subjected to a double-blind peer review process. The acceptance/rejection of the article is solely based on the comments provided by the reviewers and final approval of the editor-in-chief. Editorial Board Member’s such as Akala EO, Cheung B, Narkis M, Chu W, Bai X, Choi C, Lyubchenko Y, Filanovsky B, Bawa R, Yanlian Y, Yang Y, Atif M, Ribeiro APC, Aggarwal A, Ambrosio L, Renat R, Cennamo N, Kwang-Hee, Kim, Espid E, Haidong L, Vasile C, Manno D, Ferenz KB, Hariz A, Francis LD, HuangWM, Wang Q, Mohankandhasamy R, Mujasam K, Zhang C joined in the editorial team, will help in strengthening the coordination and management of the journal.

In case of social media and digital marketing our Journal is playing an active role in Twitter, what’s app, LinkedIn, G-suite and outlook mailing etc. A Metrics based on statistical representation of global users for Journal of Nanoscience and Nanomedicine. The visitor’s traffic is the benchmark for the success of any scientific journal and the Journal of Nanoscience and Nanomedicine is constantly attracting viewers across the world through the major source named Google Analytics. According to the Google Analytics, more than 1,994 readers are visiting to our journal websites for submitting manuscripts, to browse the latest research published on nanomedicine and to refer the published content for conceptualizing their research study, deriving research hypotheses, case reports and validating their contributions. Readers from the major countries including United States, United Kingdom, India, Egypt and Nigeria visit our journal domain to learn about the ongoing research activities in this field.

Any papers that you wish to submit for Journal of Nanoscience and Nanomedicine can submit through online either individually or collaboratively, are much appreciated and will make a substantial contribution to the early development and success of the journal. I would like to thank for the constant support of Board Members and intellectual generosity of the readers and contributors (authors and reviewers) of Journal of Nanoscience and Nanomedicine.